"OK 2004 Study (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects"

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

May 31, 2007

Conditions
HIV Infection
Interventions
DRUG

Stopping nucleosides and continuing lopinavir/ritonavir monotherapy

Trial Locations (28)

18014

Hospital Virgen de las Nieves, Granada

20014

Hospital de Donostia, San Sebastián

28006

Hospital La Princesa, Madrid

28007

Hospital Gregorio Marañón, Madrid

28034

Hospital Ramón y Cajal, Madrid

28040

Fundación Jiménez Díaz, Madrid

Hospital Clínico San Carlos, Madrid

28041

Hospital 12 de Octubre, Madrid

28880

Hospital U. Príncipe de Asturias, Alcalá de Henares

35500

Hospital Insular, Las Palmas de Gran Canaria

38010

Hospital Universitario de Canarias, Santa Cruz de Tenerife

41009

Hospital Virgen Macarena, Seville

41014

Hospital Nuestra Señora de Valme (Sevilla), Seville

46009

Hospital La Fe, Valencia

46010

Hospital Clínico de Valencia, Valencia

46014

Hospital General de Valencia, Valencia

46017

Hospital Dr. Peset, Valencia

48013

Hospital de Basurto, Bilbao

50010

Hospital Miguel Servet, Zaragoza

362004

Hospital Xeral Cies, Vigo

03010

Hospital General de Alicante, Alicante

03202

Hospital General de Elche, Elche

08003

Hospital del Mar, Barcelona

08025

Hospital Sant Creu i Sant Pau, Barcelona

08036

Hospital Clinic i Provincial, Barcelona

08916

Hospital Germans Trias i Pujol, Barcelona

08907

Hospital de Bellvitge, L'Hospitalet de Llobregat

28 046

Hospital La Paz, Madrid

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pulido, Federico, M.D.

INDIV

collaborator

Abbott

INDUSTRY

lead

Arribas, Jose R., M.D.

INDIV